Six Life Science Firms Close Q3 with an IPO, More Are on the Way | Enterpreneurship
Want create site? Find Free WordPress Themes and plugins.
The window for life science IPOs is still open, and five biotechs and one medical device company chose the last week of the third quarter to make their stock market debuts. Gritstone Oncology (NASDAQ: GRTS) closed out the week by raising $100 million in an upsized IPO.
On Thursday night, Emeryville, CA-based Gritstone priced its offering of 6.6 million shares at $15 apiece. The cancer drug company had planned to sell 6 million shares in the range of $13 to $15 each. According to its prospectus, Gritstone will use up to $25 million of the IPO cash to fund… Read more »
Reprints | Share: 
UNDERWRITERS AND PARTNERS
Did you find apk for android? You can find new Free Android Games and apps.